IVBT (Innovation1 Biotech) LT-Debt-to-Total-Asset: 4.55 (As of Feb. 2024)


IVBT Innovation1 Biotech Inc IVBT
12 GF Score
Price $0.00
View Full Analysis

What is Innovation1 Biotech LT-Debt-to-Total-Asset?

Innovation1 Biotech IVBT 12 LT-Debt-to-Total-Asset is 4.55 as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Innovation1 Biotech's long-term debt to total assests ratio for the quarter that ended in Feb. 2024 was 4.55.

Innovation1 Biotech's long-term debt to total assets ratio increased from Feb. 2023 (0.01) to Feb. 2024 (4.55). It may suggest that Innovation1 Biotech is progressively becoming more dependent on debt to grow their business.

Innovation1 Biotech  (OTCPK:IVBT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Innovation1 Biotech LT-Debt-to-Total-Asset Related Terms

Innovation1 Biotech LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech LT-Debt-to-Total-Asset Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.01 2.88

Innovation1 Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.03 2.88 20.75 4.55
IVBT
12GF Score
Innovation1 Biotech Inc IVBT
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovation1 Biotech LT-Debt-to-Total-Asset Calculation

Innovation1 Biotech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

LT Debt to Total Assets (A: Aug. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Aug. 2023 )/Total Assets (A: Aug. 2023 )
=0.219/0.076
=

Innovation1 Biotech's Long-Term Debt to Total Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

LT Debt to Total Assets (Q: Feb. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Feb. 2024 )/Total Assets (Q: Feb. 2024 )
=0.555/0.122
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 4.55 mean?
Innovation1 Biotech (IVBT) has a LT-Debt-to-Total-Asset of 4.55 as of Feb. 2024. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Innovation1 Biotech and its competitors.
Is Innovation1 Biotech's LT-Debt-to-Total-Asset too high?
Innovation1 Biotech's current LT-Debt-to-Total-Asset is 4.55. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Innovation1 Biotech's LT-Debt-to-Total-Asset compare to NVIV and PXMD?
Innovation1 Biotech's LT-Debt-to-Total-Asset of 4.55 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Diversified Financial Services company?
A good LT-Debt-to-Total-Asset depends on the Diversified Financial Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Innovation1 Biotech and its competitors. Innovation1 Biotech's current LT-Debt-to-Total-Asset is 4.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation1 Biotech stock overvalued right now?
Innovation1 Biotech (IVBT) has a current LT-Debt-to-Total-Asset of 4.55. The current LT-Debt-to-Total-Asset is 4.55. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current LT-Debt-to-Total-Asset is 4.55 as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Address 7 Grand View Avenue, Somerville, MA, USA, 02143
Innovation1 Biotech Inc is a shell company.
12GF Score

Get the complete analysis for IVBT

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price